<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Takikawa T</submitter><funding>Japan Society for the Promotion of Science</funding><pagination>9275</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9409091</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(16)</volume><pubmed_abstract>Interactions between pancreatic cancer cells and pancreatic stellate cells (PSCs) play an important role in the progression of pancreatic cancer. Recent studies have shown that cellular senescence and senescence-associated secretory phenotype factors play roles in the progression of cancer. This study aimed to clarify the effects of senescence-induced PSCs on pancreatic cancer cells. Senescence was induced in primary-cultured human PSCs (hPSCs) through treatment with hydrogen peroxide or gemcitabine. Microarray and Gene Ontology analyses showed the alterations in genes and pathways related to cellular senescence and senescence-associated secretory phenotype factors, including the upregulation of C-X-C motif chemokine ligand (CXCL)-1, CXCL2, and CXCL3 through the induction of senescence in hPSCs. Conditioned media of senescent hPSCs increased the proliferation-as found in an assessment with a BrdU incorporation assay-and migration-as found in an assessment with wound-healing and two-chamber assays-of pancreatic cancer AsPC-1 and MIAPaca-2 cell lines. SB225002, a selective CXCR2 antagonist, and SCH-527123, a CXCR1/CXCR2 antagonist, attenuated the effects of conditioned media of senescent hPSCs on the proliferation and migration of pancreatic cancer cells. These results suggest a role of CXCLs as senescence-associated secretory phenotype factors in the interaction between senescent hPSCs and pancreatic cancer cells. Senescent PSCs might be novel therapeutic targets for pancreatic cancer.</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Senescent Human Pancreatic Stellate Cells Secrete CXCR2 Agonist CXCLs to Promote Proliferation and Migration of Human Pancreatic Cancer AsPC-1 and MIAPaCa-2 Cell Lines.</pubmed_title><pmcid>PMC9409091</pmcid><funding_grant_id>19K17420 to T.T., 20K08300 to S.H., and 22H03051 to A.M.</funding_grant_id><pubmed_authors>Tanaka Y</pubmed_authors><pubmed_authors>Matsumoto R</pubmed_authors><pubmed_authors>Takikawa T</pubmed_authors><pubmed_authors>Hamada S</pubmed_authors><pubmed_authors>Kataoka F</pubmed_authors><pubmed_authors>Sasaki A</pubmed_authors><pubmed_authors>Masamune A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Senescent Human Pancreatic Stellate Cells Secrete CXCR2 Agonist CXCLs to Promote Proliferation and Migration of Human Pancreatic Cancer AsPC-1 and MIAPaCa-2 Cell Lines.</name><description>Interactions between pancreatic cancer cells and pancreatic stellate cells (PSCs) play an important role in the progression of pancreatic cancer. Recent studies have shown that cellular senescence and senescence-associated secretory phenotype factors play roles in the progression of cancer. This study aimed to clarify the effects of senescence-induced PSCs on pancreatic cancer cells. Senescence was induced in primary-cultured human PSCs (hPSCs) through treatment with hydrogen peroxide or gemcitabine. Microarray and Gene Ontology analyses showed the alterations in genes and pathways related to cellular senescence and senescence-associated secretory phenotype factors, including the upregulation of C-X-C motif chemokine ligand (CXCL)-1, CXCL2, and CXCL3 through the induction of senescence in hPSCs. Conditioned media of senescent hPSCs increased the proliferation-as found in an assessment with a BrdU incorporation assay-and migration-as found in an assessment with wound-healing and two-chamber assays-of pancreatic cancer AsPC-1 and MIAPaca-2 cell lines. SB225002, a selective CXCR2 antagonist, and SCH-527123, a CXCR1/CXCR2 antagonist, attenuated the effects of conditioned media of senescent hPSCs on the proliferation and migration of pancreatic cancer cells. These results suggest a role of CXCLs as senescence-associated secretory phenotype factors in the interaction between senescent hPSCs and pancreatic cancer cells. Senescent PSCs might be novel therapeutic targets for pancreatic cancer.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2024-11-15T06:54:28.69Z</modification><creation>2024-11-15T06:54:28.69Z</creation></dates><accession>S-EPMC9409091</accession><cross_references><pubmed>36012531</pubmed><doi>10.3390/ijms23169275</doi></cross_references></HashMap>